Franklin Resources’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $486M | Sell |
3,236,065
-212,128
| -6% | -$23.1M | 0.11% | 182 |
|
|
2026
Q1 | $319M | Buy |
3,448,193
+86,646
| +3% | +$8.7M | 0.08% | 237 |
|
|
2025
Q4 | $343M | Buy |
3,361,547
+435,232
| +15% | +$38.9M | 0.08% | 216 |
|
|
2025
Q3 | $183M | Buy |
2,926,315
+606,368
| +26% | +$33M | 0.05% | 320 |
|
|
2025
Q2 | $121M | Buy |
2,319,947
+1,018,144
| +78% | +$45.5M | 0.03% | 400 |
|
|
2025
Q1 | $55.5M | Buy |
1,301,803
+361,757
| +38% | +$15.6M | 0.02% | 573 |
|
|
2024
Q4 | $28.7M | Sell |
940,046
-5,979
| -0.6% | -$168K | 0.01% | 797 |
|
|
2024
Q3 | $20.2M | Sell |
946,025
-123,938
| -12% | -$3.51M | 0.01% | 893 |
|
|
2024
Q2 | $30.9M | Buy |
1,069,963
+2,702
| +0.3% | +$62.9K | 0.01% | 712 |
|
|
2024
Q1 | $22M | Sell |
1,067,261
-301,748
| -22% | -$6.47M | 0.01% | 834 |
|
|
2023
Q4 | $37M | Buy |
1,369,009
+131,646
| +11% | +$3.45M | 0.02% | 597 |
|
|
2023
Q3 | $36.7M | Buy |
1,237,363
+5,244
| +0.4% | +$184K | 0.02% | 579 |
|
|
2023
Q2 | $44.1M | Buy |
1,232,119
+32,055
| +3% | +$921K | 0.02% | 560 |
|
|
2023
Q1 | $28.1M | Sell |
1,200,064
-500,130
| -29% | -$14.3M | 0.01% | 684 |
|
|
2022
Q4 | $46.2M | Sell |
1,700,194
-1,261,202
| -43% | -$57.7M | 0.02% | 549 |
|
|
2022
Q3 | $159M | Buy |
2,961,396
+191,898
| +7% | +$9.85M | 0.09% | 277 |
|
|
2022
Q2 | $112M | Buy |
2,769,498
+157,961
| +6% | +$7.83M | 0.06% | 360 |
|
|
2022
Q1 | $173M | Buy |
2,611,537
+1,229,021
| +89% | +$84.1M | 0.07% | 325 |
|
|
2021
Q4 | $138M | Sell |
1,382,516
-369,428
| -21% | -$38.2M | 0.05% | 382 |
|
|
2021
Q3 | $219M | Buy |
1,751,944
+31,819
| +2% | +$3.78M | 0.08% | 277 |
|
|
2021
Q2 | $214M | Sell |
1,720,125
-91,066
| -5% | -$12.2M | 0.08% | 276 |
|
|
2021
Q1 | $276M | Buy |
1,811,191
+191,472
| +12% | +$28.9M | 0.11% | 220 |
|
|
2020
Q4 | $209M | Buy |
1,619,719
+293,670
| +22% | +$33.8M | 0.09% | 252 |
|
|
2020
Q3 | $148M | Buy |
1,326,049
+429,441
| +48% | +$39.3M | 0.07% | 289 |
|
|
2020
Q2 | $74.3M | Sell |
896,608
-22,816
| -2% | -$1.84M | 0.04% | 455 |
|
|
2020
Q1 | $64M | Sell |
919,424
-5,547
| -0.6% | -$426K | 0.04% | 406 |
|
|
2019
Q4 | $72.3M | Buy |
924,971
+254,288
| +38% | +$18.3M | 0.04% | 450 |
|
|
2019
Q3 | $42.8M | Sell |
670,683
-112,089
| -14% | -$9.87M | 0.02% | 571 |
|
|
2019
Q2 | $67.6M | Sell |
782,772
-253,292
| -24% | -$19.3M | 0.04% | 480 |
|
|
2019
Q1 | $79.4M | Sell |
1,036,064
-183,884
| -15% | -$10.2M | 0.04% | 424 |
|
|
2018
Q4 | $45.9M | Buy |
+1,219,948
| New | +$44.9M | 0.03% | 497 |
|
Other funds holding GH
DTC
Franklin Resources's GH Position: Q2 2026 in Review
Franklin Resources reduced its Guardant Health (GH) stake by 6.2% in Q2 2026, selling an estimated $23.1M and leaving 3,236,065 shares worth $486M. The position accounts for 0.11% of the portfolio, ranked #182.
Franklin Resources first reported a position in GH in Q4 2018 and has held it in 31 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Franklin Resources held 3,236,065 shares of Guardant Health worth $486M as of Q2 2026.
- Franklin Resources sold 212,128 Guardant Health shares in Q2 2026, an estimated $23.1M.
- Guardant Health made up 0.11% of Franklin Resources's portfolio in Q2 2026, its #182 holding.
- Franklin Resources first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.